Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DR26FDKR9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,727
Award facts
- Contract value 100% obligated
- $7,727.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $7,727.36 delivery order to DMS Pharmaceutical Group Inc. on July 14, 2026, for NUCALA 100 mg/ml auto-injector supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois. Place of performance is Park Ridge, IL. The order carries a firm fixed price and ultimate completion date of July 15, 2026.
Quick answers
Who was awarded contract SPE2DR26FDKR9?
SPE2DR26FDKR9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26FDKR9 worth?
The government has obligated $7,727 on SPE2DR26FDKR9.
Is contract SPE2DR26FDKR9 an order under another contract?
Yes. SPE2DR26FDKR9 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDKR9 competed?
The extent of competition for SPE2DR26FDKR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award